Expertise in
6
conditions

Ingrid E. Desar

Nijmegen, GE, NL 
Expertise in
6
conditions
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Ingrid Desar practices in Nijmegen, Netherlands. Ms. Desar is highly rated in 6 conditions, according to our data. Her top areas of expertise are Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Angiosarcoma, Hemangioendothelioma, and Nephrectomy.

Her clinical research consists of co-authoring 121 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Nijmegen, GE 6525GA, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Validation of Mutation Analysis in Circulating Tumor DNA With a ddPCR Assay as Diagnostic and Follow-up Tool for Patients With a KIT Exon 11 Mutated GIST: GALLOP-11
Validation of Mutation Analysis in Circulating Tumor DNA With a ddPCR Assay as Diagnostic and Follow-up Tool for Patients With a KIT Exon 11 Mutated GIST: GALLOP-11
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Other
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Avapritinib, Regorafenib
Study Phase: Phase 3
View 1 Less Clinical Trial

121 Total Publications

Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST.
Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST.
Journal: Cancers
Published: December 10, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Desar's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile